FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
| Brand name | AIRDUO RESPICLICK |
|---|---|
| Active ingredient | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE |
| Strength | 0.055MG/INH;EQ 0.014MG BASE/INH |
| Dosage form | POWDER |
| Route | INHALATION |
| Modality | Small molecule |
| FDA approval | January 2017 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11969544*PED | February 2040 | — |
| 11969544 | August 2039 | product |
| 9415008*PED | April 2035 | — |
| 9066957*PED | April 2035 | — |
| 9415008 | October 2034 | product |
| 9066957 | October 2034 | product |
| 10195375*PED | August 2031 | — |
| 10195375 | February 2031 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.